Axsome Therapeutics operates as a biopharmaceutical company focusing on central nervous system (CNS) disorders, facing competition from specialized neuroscience drug developers and major pharmaceutical corporations. Key competitors include enterprises such as Jazz Pharmaceuticals, Supernus Pharmaceuticals, Intra-Cellular Therapies, Acadia Pharmaceuticals, and larger multinational drug manufacturers developing treatments for psychiatry, neurology, and rare central nervous system conditions.